Notices for publication in the OJ nº T-182/17 of Tribunal General de la Unión Europea, May 05, 2017

• Resolution Date: May 05, 2017
• Issuing Organization: Tribunal General de la Unión Europea
• Decision Number: T-182/17

Action brought on 20 March 2017 - Novartis v EUIPO - Chiesi Farmaceutici (AKANTO)

(Case T-182/17)

Language in which the application was lodged: English

Parties

Applicant: Novartis AG (Basel, Suisse) (represented by: L. Junquera Lara, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Chiesi Farmaceutici SpA (Parma, Italy)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant

Trade mark at issue: EU word mark ‘AKANTO’ - Application for registration No 13 289 781

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 9 January 2017 in Case R 531/2016-1

Form of order sought

The applicant claims that the Court should:

annul the contested decision;

declare that Article 8(1)(b) of Regulation No 207/2009 does not preclude the sign at issue (European trade mark No 13 289 781) in respect of the goods in class 5 described in...